Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000660745 | SCV000782980 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771580 | SCV000904164 | likely benign | Familial hypercholesterolemia | 2018-03-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000861885 | SCV001002298 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001560960 | SCV001783473 | likely benign | not provided | 2020-12-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16465619) |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001560960 | SCV002046501 | benign | not provided | 2020-12-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002397343 | SCV002714262 | likely benign | Cardiovascular phenotype | 2018-03-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |